Q-Line Biotech Limited (QLINE)

—

Key Ratios

Market Cap—

Current Price—

Previous Close—

High / Low (52w)—

Volume—

Avg Vol (1W)—

Avg Vol (1M)—

Stock P/E0

Book Value₹1,206

Dividend Yield—

ROE23.58%

ROA—

Revenue (TTM)—

Revenue Growth—

Profit Margin—

Total Debt—

Shares Outstanding—

Face Value—

EPS (TTM)₹155.64

P/B0

Debt / Equity0.75

50 DMA—

200 DMA—

Day change—

Pros

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023
Revenue	₹323 Cr	₹206 Cr	₹185 Cr
EBITDA	₹76 Cr	₹37 Cr	₹34 Cr
Net Profit	₹28 Cr	₹34 Cr	₹32 Cr
EPS	28.63	21.87	20.38

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023
Total Assets	₹455 Cr	₹339 Cr	₹252 Cr
Total Liabilities	₹266 Cr	₹177 Cr	₹124 Cr
Equity	₹190 Cr	₹162 Cr	₹127 Cr
Total Debt	₹82 Cr	₹35 Cr	₹14 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023
Operating	₹6 Cr	₹-15 Cr	₹37 Cr
Investing	₹-59 Cr	₹-45 Cr	₹-26 Cr
Financing	₹53 Cr	₹17 Cr	₹26 Cr
Free Cash Flow	₹6 Cr	₹-15 Cr	₹37 Cr

Shareholding

Promoter 67.51% Institutions 11.81% Public 20.67%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search